Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cyproheptadine hydrochloride
Drug ID BADD_D00553
Description Cyproheptadine is a potent competitive antagonist of both serotonin and histamine receptors.[L32474] It is used primarily to treat allergic symptoms, though it is perhaps more notable for its use in appetite stimulation[L32519] and its off-label use in the treatment of serotonin syndrome.[A231274]
Indications and Usage For treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis due to inhalant allergens and foods, mild uncomplicated allergic skin manifestations of urticaria and angioedema, amelioration of allergic reactions to blood or plasma, cold urticaria, dermatographism, and as therapy for anaphylactic reactions adjunctive to epinephrine.
Marketing Status Discontinued
ATC Code R06AX02
DrugBank ID DB00434
KEGG ID D02234
MeSH ID D003533
PubChem ID 13770
TTD Drug ID D00TLN
NDC Product Code 39328-544; 71335-0211; 76385-130; 50268-189; 64980-504; 23155-703; 16571-805; 70710-1110; 50090-4724; 50742-190; 71335-0758; 52817-210; 70771-1076; 46438-0036; 27808-099; 51991-838; 71335-1107; 66577-014; 64380-795; 71205-024; 17337-0508; 62991-1232; 71335-1859; 42291-225; 51407-272; 49452-2409; 55700-700; 70752-101; 63629-2062; 24689-816; 70518-2414; 66577-040; 38779-1226; 71554-003; 50090-5491; 70752-107; 0527-1949; 0115-1757; 71205-989; 10135-638; 69367-246; 66689-333; 72789-102
Synonyms Cyproheptadine | Dihexazin | Peritol | Viternum | Antergan | Periactin
Chemical Information
Molecular Formula C21H22ClN
CAS Registry Number 969-33-5
SMILES CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Agitation19.06.02.001; 17.02.05.012--
Agranulocytosis01.02.03.001--Not Available
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Chest discomfort08.01.08.019; 02.02.02.009; 22.02.08.001--Not Available
Chills15.05.03.016; 08.01.09.001--
Cholestasis09.01.01.001--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Constipation07.02.02.001--
Conversion disorder19.24.01.001--Not Available
Coordination abnormal17.02.02.004--Not Available
Diarrhoea07.02.01.001--
Diplopia17.17.01.005; 06.02.06.002--Not Available
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dry mouth07.06.01.002--
Dry throat22.02.05.004; 07.06.01.005--Not Available
Dyspepsia07.01.02.001--
Dysuria20.02.02.002--
Euphoric mood19.04.02.006--
Extrasystoles02.03.02.003--Not Available
Fatigue08.01.01.002--
Haemolytic anaemia01.06.03.002--Not Available
Hallucination19.10.02.002--
Headache17.14.01.001--
Hepatic failure09.01.03.002--
Hepatic function abnormal09.01.02.001--Not Available
Hepatitis09.01.07.004--Not Available
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hypotension24.06.03.002--
Increased appetite14.03.01.003; 08.01.09.027--Not Available
Insomnia19.02.01.002; 17.15.03.002--
The 1th Page    1 2 3    Next   Last    Total 3 Pages